Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Iran’s Korea Medical R&D Investment Delayed By Sanctions

This article was originally published in PharmAsia News

Executive Summary

Amid the still uncertain timing of major countries' lifting of economic sanctions against Iran, construction of a planned Iranian traditional medical research institute in South Korea's Osong Biovalley has been postponed to the first half of next year from this year. In April, an Iranian consortium signed an agreement to invest $2bn in the biocluster to build medical facilities and develop new drugs.



Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts